Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

By Vijay Kumar Malesu In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of ...

Adelle Omondi has been accused of tarnishing the name of Mash Bus Company after she accused them of refusing to give her the ...

Michael Tadros, MD, MPH, discusses how lessons learned from HCV treatment could improve the management of metabolic ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

Why This Beef Stew Deserves A Spot In Your Weekly Rotation This isn’t your average beef stew—it’s a rich, creamy, ...

A Wild West weekend at Texas Motor Speedway for the three NASCAR national series ended with three overtime finishes. From the ...